Efficacy and Safety of Direct Anti HCV Drugs in the Treatment of SARS-COV-2 (COVID-19) (CCOVID-19)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04535869 |
Recruitment Status : Unknown
Verified August 2020 by Mahmoud Elbendary, Mansoura University.
Recruitment status was: Recruiting
First Posted : September 2, 2020
Last Update Posted : February 24, 2021
|
Sponsor:
Mansoura University
Information provided by (Responsible Party):
Mahmoud Elbendary, Mansoura University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Unknown |
---|---|
Estimated Primary Completion Date : | April 1, 2021 |
Estimated Study Completion Date : | September 3, 2021 |
Publications of Results:
Other Publications:
Other Publications: